SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
人类 SCLC 中的第二信使和受体系统
基本信息
- 批准号:3916617
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:antibody specificity bombesin cell cell interaction cell growth regulation cell membrane cellular oncology cholera toxin crosslink drug design /synthesis /production gastrins guanosine diphosphate hormone binding protein hormone receptor human tissue laboratory rat molecular oncology neoplasm /cancer therapy neoplastic cell oncoproteins peptide hormone pertussis toxin pituitary gland second messengers small cell lung cancer
项目摘要
Previous studies with small cell lung cancer (SCLC) cell lines have
demonstrated that gastrin-releasing peptide (GRP), the mammalian
counterpart to bombesin, is expressed in a significant fraction of
SCLC lines. To assess its role in causing autocrine stimulation,
initial experiments attempted to demonstrate specific binding to
SCLC membrane fractions, with little success. Accordingly, efforts
to define rapid physiologic responses to GRP were undertaken.
These studies demonstrated clearly that in 5/11 SCLC cell lines
tested there was evidence of calcium mobilization following GRP or
bombesin stimulation. The structure-activity relationship of this
effect was in accord with that expected for GRP receptors in gut,
brain and anterior pituitary cells. Further studies focused on the
relationship of this response to inositol phosphate metabolism.
In a SCLC cell line with a brisk response to GRP with increased
intracellular calcium, there was evidence of increased inositol
1,4,5 trisphosphate within seconds of addition of bombesin
congeners. Both the mobilization of calcium and inositol phosphate
turnover were inhibited by cholera toxin and active phorbol esters.
In the presence of pertussis toxin there was also a less complete
stimulation of inositol phosphate turnover. In corollary studies
it was demonstrated that the cell lines with the best response to
bombesin showed constitutive expression of L-myc and prepro GRP
without expression of c- or N-myc. In contrast, cell lines without
evidence of response to bombesin had constitutive N- or c-myc
expression.
These studies suggest that an order of progressively malignant and
distinct phenotypes can be defined in SCLC cell lines. A most
"differentiated" cell line would be those which produce and respond
to GRP, and also produce L-myc. A less differentiated cell line
would neither produce nor respond to GRP and express abundant c-
or N-myc. GRP (+), L-myc (+), c-myc (-), and N-myc (-) cell lines
would represent those in which an effort to block a potential
autocrine loop involving GRP might be most successful.
以前对小细胞肺癌(SCLC)细胞系的研究表明,
证明了胃泌素释放肽(GRP),哺乳动物
蛙皮素的对应物,在
SCLC线路。 为了评估其在引起自分泌刺激中的作用,
最初的实验试图证明特异性结合
SCLC膜组分,但收效甚微。 因此,努力
以确定对GRP的快速生理反应。
这些研究清楚地表明,在5/11的SCLC细胞系中,
测试有证据表明,钙动员后,GRP或
蛙皮素刺激 这种结构与活性的关系
作用与对肠道中GRP受体预期的雅阁,
脑和垂体前叶细胞。 进一步的研究集中在
这种反应与磷酸肌醇代谢的关系。
在SCLC细胞系中,对GRP的反应活跃,
细胞内钙,有证据表明增加肌醇
在添加蛙皮素的几秒钟内1,4,5三磷酸盐
同源物。 钙和磷酸肌醇的动员
霍乱毒素和活性佛波醇酯抑制周转。
在百日咳毒素的存在下,
刺激磷酸肌醇周转。 在推论研究中,
结果表明,对以下物质具有最佳应答的细胞系
蛙皮素呈组成型表达,L-myc和prepro GRP
而不表达c-或N-myc。 相反,没有
对蛙皮素反应的证据具有组成性N-或c-myc
表情
这些研究表明,进行性恶性和
可以在SCLC细胞系中定义不同的表型。 一个最
“分化的”细胞系将是那些产生和响应
转化成GRP,并产生L-myc。 分化程度较低的细胞系
既不产生也不响应GRP,并表达丰富的c-
或N-myc。 GRP(+)、L-myc(+)、c-myc(-)和N-myc(-)细胞系
将代表那些试图阻止潜在的
涉及GRP的自分泌环可能是最成功的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E SAUSVILLE其他文献
E SAUSVILLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E SAUSVILLE', 18)}}的其他基金
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
针对细胞膜的毒素——信号转导的破坏
- 批准号:
3752418 - 财政年份:
- 资助金额:
-- - 项目类别:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
蛋白激酶拮抗剂的临床前和临床药理学
- 批准号:
3752419 - 财政年份:
- 资助金额:
-- - 项目类别:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
G 蛋白效应物作为抗肿瘤治疗的靶点
- 批准号:
3774670 - 财政年份:
- 资助金额:
-- - 项目类别:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
人类 SCLC 中的第二信使和受体系统
- 批准号:
3939550 - 财政年份:
- 资助金额:
-- - 项目类别:
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES
蛋白激酶拮抗剂——临床前和临床研究
- 批准号:
2464490 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
Bombesin修饰的纳米粒肿瘤靶向性及靶向递药效果研究
- 批准号:81603018
- 批准年份:2016
- 资助金额:17.3 万元
- 项目类别:青年科学基金项目
Bombesin导向的肿瘤细胞选择性促凋亡分子优化设计及PEG定点修饰
- 批准号:81072566
- 批准年份:2010
- 资助金额:36.0 万元
- 项目类别:面上项目
相似海外基金
Optimized Bombesin Analogues for the Imaging and Treatment of Cancer
用于癌症成像和治疗的优化铃蟾肽类似物
- 批准号:
415328 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Studentship Programs
Investigation for diagnosis and treatment of prostate cancer using radiohalogen labeled Bombesin derivative
使用放射性卤素标记的铃蟾肽衍生物诊断和治疗前列腺癌的研究
- 批准号:
16H07099 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Research Activity Start-up
Design and Evaluation of Hypoxia Enhanced Bombesin Analogs for Prostate Cancer
缺氧增强铃蟾肽类似物治疗前列腺癌的设计和评价
- 批准号:
8013460 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Design and Evaluation of Hypoxia Enhanced Bombesin Analogs for Prostate Cancer
缺氧增强铃蟾肽类似物治疗前列腺癌的设计和评价
- 批准号:
8232144 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Design and Evaluation of Hypoxia Enhanced Bombesin Analogs for Prostate Cancer
缺氧增强铃蟾肽类似物治疗前列腺癌的设计和评价
- 批准号:
8033262 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer
铃蟾肽激活结直肠癌中癌相关成纤维细胞
- 批准号:
8141290 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer
铃蟾肽激活结直肠癌中癌相关成纤维细胞
- 批准号:
8312340 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer
铃蟾肽激活结直肠癌中癌相关成纤维细胞
- 批准号:
8522262 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer
铃蟾肽激活结直肠癌中癌相关成纤维细胞
- 批准号:
7921556 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal Cancer
铃蟾肽激活结直肠癌中癌相关成纤维细胞
- 批准号:
7589112 - 财政年份:2009
- 资助金额:
-- - 项目类别: